Business profile not generated.
Run python -m application.cli.business_profile run --market US --one SBFM, then regenerate the site.
A filing-first public record from Lucide House.
Issue 000 | U.S. Pilot | US
Sunshine Biopharma Inc.
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Business profile not generated.
Run python -m application.cli.business_profile run --market US --one SBFM, then regenerate the site.
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
2019-12-31
10-K
USD
|
2018-12-31
10-K
USD
|
2017-12-31
10-K
USD
|
2016-12-31
10-K
USD
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36,305,891 | 34,874,283 | 24,092,787 | 4,345,603 | 228,426 | 71,410 | 21,121 | 447,200 | 0 | n/a |
| Operating Income | -6,227,029 | -5,812,121 | -4,785,299 | -27,000,750 | -2,440,134 | -576,874 | -641,636 | -1,166,537 | -857,190 | -993,108 |
| Net Income | -5,975,352 | -5,134,116 | -4,506,044 | -26,744,440 | -12,436,447 | -2,784,091 | -1,660,291 | -2,156,155 | -1,040,236 | -3,496,687 |
| Cash From Operations | -5,331,073 | -12,531,180 | -8,775,111 | -5,248,358 | -1,829,128 | -657,299 | -495,798 | -512,806 | -543,520 | -314,182 |
| Capex | -174,491 | -1,657,055 | -82,251 | -193,982 | 0 | -1,191 | -860 | -18,850 | -3,718 | -3,439 |
| Free Cash Flow | -5,505,564 | -14,188,235 | -8,857,362 | -5,442,340 | -1,829,128 | -658,490 | -496,658 | -531,656 | -547,238 | -317,621 |
| Cash And Equivalents | n/a | n/a | n/a | 21,826,437 | 2,045,167 | 989,888 | 40,501 | 115,216 | 107,532 | 57,453 |
| Accounts Receivable | 3,459,864 | 3,868,418 | 2,552,362 | 1,912,153 | 7,798 | 1,916 | 430 | 94,955 | 0 | n/a |
| Inventory | 13,472,025 | 11,278,105 | 5,734,755 | 3,289,945 | 105,650 | 23,771 | 15,910 | 0 | n/a | n/a |
| Total Current Assets | 26,853,581 | 25,966,349 | 24,890,055 | 27,312,334 | 2,195,830 | 1,025,943 | 65,686 | 211,512 | 117,199 | 58,460 |
| Total Assets | 30,079,167 | 30,560,392 | 27,346,961 | 29,243,848 | 2,202,891 | 1,045,474 | 98,142 | 1,146,571 | 257,485 | 64,404 |
| Total Current Liabilities | 6,443,922 | 6,314,914 | 5,551,836 | 6,931,014 | 91,229 | 1,051,305 | 833,527 | 912,477 | 751,138 | 274,104 |
| Total Liabilities | 7,040,707 | 7,059,638 | 6,139,600 | 7,616,278 | 1,991,229 | 2,000,311 | 833,527 | 1,202,324 | 830,848 | 274,104 |
| Shareholders Equity | 23,038,460 | 23,500,754 | 21,207,361 | 21,627,570 | 211,662 | -954,837 | -735,385 | -55,753 | -573,363 | -209,700 |
| Shares Outstanding | 4,905,945 | 2,580,098 | 28,024,290 | 22,585,632 | 2,591,240 | 346,419,296 | 35,319,990 | 85,652,400 | 918,736,498 | 769,399,858 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | n/a | 701,749 | 24,331,908 | 15,180,868 | 2,612,061 | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | 4,157,086 | 701,749 | 24,331,908 | 15,180,868 | 2,612,061 | 204,096,338 | 10,932,813 | 60,936,164 | 872,685,608 | 424,874,458 |
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,088,765 | 8,577,141 | 9,417,179 | 9,410,230 | 8,901,341 | 9,594,992 | 8,435,178 | 9,303,067 | 7,541,046 | 7,680,201 | 5,957,668 | 5,560,865 | 4,894,053 | 3,939,843 | 132,808 | 150,307 | 122,645 | 85,118 | 50,376 | 52,874 |
| Operating Income | -1,395,597 | -1,790,011 | -1,086,613 | -2,054,655 | -1,295,750 | -2,037,722 | -1,106,353 | -1,317,457 | -1,350,589 | -1,187,221 | -779,474 | -989,623 | -1,828,981 | -23,363,610 | -1,717,980 | -695,796 | -1,223,364 | -279,631 | -496,259 | -388,598 |
| Net Income | -1,243,869 | -2,140,927 | -883,820 | -1,770,834 | -1,179,771 | -2,158,212 | -1,197,803 | -494,300 | -1,283,801 | -1,250,024 | -651,482 | -902,108 | -1,702,430 | -23,512,315 | -1,457,019 | -538,872 | -1,236,234 | 667,116 | -4,039,383 | -2,879,054 |
| Cash From Operations | -2,072,100 | -1,616,006 | -727,800 | -1,273,432 | -1,713,835 | -3,407,282 | -1,360,956 | -4,577,783 | -3,185,159 | -2,689,676 | -457,289 | -3,778,040 | -1,850,106 | -2,246,612 | -1,123,736 | -573,802 | -1,304,208 | -312,113 | -600,808 | -618,852 |
| Capex | -5,129 | 1,039 | -8,040 | -160,000 | -7,490 | -102,600 | -517,005 | -974,513 | -62,937 | n/a | -9,634 | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | -2,077,229 | -1,614,967 | -735,840 | -1,433,432 | -1,721,325 | -3,509,882 | -1,877,961 | -5,552,296 | -3,248,096 | n/a | -466,923 | n/a | n/a | n/a | -1,123,736 | n/a | n/a | n/a | n/a | n/a |
| Cash And Equivalents | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19,729,491 | 19,294,218 | 21,826,437 | 40,555,931 | 41,727,775 | 13,177,625 | 2,045,167 | 2,386,608 | 1,735,094 |
| Total Current Assets | 24,783,176 | 26,853,581 | 27,967,232 | 27,851,018 | 24,480,980 | 25,966,349 | 25,981,863 | 25,748,520 | 28,831,224 | 24,890,055 | 25,434,859 | 26,098,709 | 24,946,947 | 27,312,334 | 40,860,574 | 41,989,322 | 13,405,367 | 2,195,830 | 2,491,683 | 1,803,586 |
| Total Liabilities | 6,413,781 | 7,040,707 | 7,288,023 | 6,280,446 | 6,484,635 | 7,059,638 | 5,017,504 | 5,811,114 | 7,079,102 | 6,139,600 | 5,686,801 | 5,300,229 | 7,561,870 | 7,616,278 | 480,209 | 104,684 | 95,234 | 1,991,229 | 3,675,847 | 2,689,778 |
| Shares Outstanding | 4,905,945 | 4,905,945 | 4,555,945 | 4,555,945 | 2,707,541 | 2,580,098 | 1,999,660 | 1,170,510 | 994,529 | 28,024,290 | 25,678,290 | 25,746,302 | 22,139,921 | 22,585,632 | 18,885,632 | 18,885,632 | 7,149,778 | 2,591,240 | 510,093,265 | 486,093,265 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | n/a | n/a | 3,925,235 | 3,604,653 | 2,703,293 | 701,749 | 1,267,565 | 49,726 | 641,310 | 24,331,908 | 25,690,449 | 25,350,263 | 22,036,272 | 15,180,868 | 18,885,632 | 15,849,518 | 5,272,856 | 2,612,061 | n/a | n/a |
| Weighted Avg Shares Basic | 4,905,945 | 4,157,086 | 4,555,945 | 4,496,108 | 2,703,293 | 701,749 | 1,267,565 | 49,726 | 641,310 | 24,331,908 | 25,690,449 | 25,350,263 | 220,363 | 15,180,868 | 18,885,632 | 15,849,518 | 5,272,856 | 2,612,061 | 508,528,048 | 478,520,336 |
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 24,783,176USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001402328/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001402328\companyfacts.json |
| Total Liabilities | 6,413,781USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001402328/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001402328\companyfacts.json |
| Cash | n/a | derived | 2026-03-31 | n/a | n/a |
| Shares Outstanding | 4,905,945 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001402328/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001402328\companyfacts.json |
| NCAV | 18,369,395USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 3.74USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 43.6% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-13; mary_accession=0001683168-26-003819; mary_cik=0001402328; gnni_supporting_filing_date=2026-05-13; internal_discount=0.436479; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.